Patient Satisfaction With the Management of a Stopped Pregnancy in the First Trimester

• Status: Not yet recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The clinical practice recommendations highlight the fact that the patient's choice concerning the management of her aborted pregnancy in the first trimester should be privileged, after clear and appropriate information on the available treatments, in order to improve his experience and reduce the negative psychological symptoms that can generate an alteration in the quality of life, in the aftermath of the loss of pregnancy.

The present study will describe the efficacy, satisfaction and tolerance of patients benefiting from medical treatment with Mifégyne® and MisoOne® versus those benefiting from surgical treatment by endo-uterine aspiration for the management of a pregnancy stopped during the first trimester at the Toulouse University Hospital

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Toulouse
• Treatments: Mifepristone

Criteria

Inclusion Criteria:

• Any adult patient presenting to the gynecological emergency department of the Paule de Viguier Hospital in Toulouse for whom a diagnosis of an arrested pregnancy in the first trimester is made

• Whose cranio-caudal length of the embryo measured by ultrasound is less than 25 mm or having a clear egg

• Having agreed to the study (written or verbal) after clear and fair information

• Who understands and reads French

Exclusion Criteria:

• Medical contraindication to treatment with Mifégyne® or MisoOne®

• Hemodynamically unstable patient requiring urgent surgical treatment.

• Protected adult patient (guardianship, curatorship, safeguard of justice)